Catalyst Wire Dossier Catalyst Wire Dossier

rFIXFc

recombinant Factor IX Fc fusion protein · Bioverativ Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for rFIXFc, covering 2014-09-04 to 2020-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B [Phase 3]

See pricing